预防医学指南

订阅

MedSci主页 / 所有栏目 / 预防医学指南

2020 CDC指南：卫生保健人员潜在暴露HCV的检测与临床管理

2020-07-24 美国疾病控制与预防中心 MMWR Recomm Rep . 2020 Jul 24;69(6):1-8.

丙型肝炎

暴露于丙型肝炎病毒(HCV)是公认的医务人员(HCP)职业风险｡在暴露后应尽快(最好48h内)对源患者和HCP进行病毒标志物的基线检测｡对于源患者，推荐首选检测HCV RNA，尤其对已知或怀疑近期有增

中文标题：

2020 CDC指南：卫生保健人员潜在暴露HCV的检测与临床管理

英文标题：

Testing and Clinical Management of Health Care Personnel Potentially Exposed to Hepatitis C Virus — CDC Guidance, United States, 2020

发布机构：

美国疾病控制与预防中心

发布日期：

2020-07-24

简要介绍：

暴露于丙型肝炎病毒(HCV)是公认的医务人员(HCP)职业风险｡在暴露后应尽快(最好48h内)对源患者和HCP进行病毒标志物的基线检测｡对于源患者，推荐首选检测HCV RNA，尤其对已知或怀疑近期有增加HCV 感染风险的行为，或无法评估其感染风险的源患者｡推荐次选先筛查丙型肝炎病毒抗体(抗HCV)，抗体阳性时再检测HCV RNA｡如果HCP的抗HCV 阳性，HCP可以与源患者的检测同步进行，或应在暴露后尽快(48h内)用同一样本进行HCV RNA 的核酸检测｡根据源患者的状态确定HCP 暴露后的追踪检测方案｡如果源患者HCV RNA 为阳性，或抗HCV 阳性但不能进行HCV RNA 检测，或HCV 感染状态未知，则HCP应在暴露后3~6周进行HCV RNA 检测｡如果HCP暴露后3~6周HCV RNA 的检测结果为阴性，应在暴露后4~6个月进行抗HCV 的最终检测｡不推荐对职业暴露于血液和其他体液的HCP 预防性使用直接作用抗病毒药物｡发现HCV RNA 阳性的患者或HCP时应及时治疗｡

相关资料下载：
[AttachmentFileName(sort=1, fileName=2020 CDC指南：卫生保健人员潜在暴露HCV的检测与临床管理.pdf)] GetToolGuiderByIdResponse(projectId=1, id=11b241c0020102d5, title=2020 CDC指南：卫生保健人员潜在暴露HCV的检测与临床管理, enTitle=Testing and Clinical Management of Health Care Personnel Potentially Exposed to Hepatitis C Virus — CDC Guidance, United States, 2020, guiderFrom=MMWR Recomm Rep . 2020 Jul 24;69(6):1-8., authorId=0, author=, summary=暴露于丙型肝炎病毒(HCV)是公认的医务人员(HCP)职业风险｡在暴露后应尽快(最好48h内)对源患者和HCP进行病毒标志物的基线检测｡对于源患者，推荐首选检测HCV RNA，尤其对已知或怀疑近期有增, cover=https://img.medsci.cn/20201118/1605632280611_2020535.jpg, journalId=0, articlesId=null, associationId=109, associationName=美国疾病控制与预防中心, associationIntro=致力于保护健康和促进预防和控制疾病，设有疾病预防控制中心咨询委员会&mdash;&mdash;联邦咨询委员会，提供卫生监测系统的监测和防止疾病暴发（包括生物恐怖主义），实施疾病预防战略，并保持国家卫生统计与各国和其他合。提供流行病学统计等数据。, copyright=0, guiderPublishedTime=Fri Jul 24 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<p>暴露于丙型肝炎病毒(HCV)是公认的医务人员(HCP)职业风险｡在暴露后应尽快(最好48h内)对源患者和HCP进行病毒标志物的基线检测｡对于源患者，推荐首选检测HCV RNA，尤其对已知或怀疑近期有增加HCV&nbsp;感染风险的行为，或无法评估其感染风险的源患者｡推荐次选先筛查丙型肝炎病毒抗体(抗HCV)，抗体阳性时再检测HCV RNA｡如果HCP的抗HCV&nbsp;阳性，HCP可以与源患者的检测同步进行，或应在暴露后尽快(48h内)用同一样本进行HCV RNA&nbsp;的核酸检测｡根据源患者的状态确定HCP&nbsp;暴露后的追踪检测方案｡如果源患者HCV RNA&nbsp;为阳性，或抗HCV&nbsp;阳性但不能进行HCV RNA&nbsp;检测，或HCV&nbsp;感染状态未知，则HCP应在暴露后3~6周进行HCV RNA&nbsp;检测｡如果HCP暴露后3~6周HCV RNA&nbsp;的检测结果为阴性，应在暴露后4~6个月进行抗HCV&nbsp;的最终检测｡不推荐对职业暴露于血液和其他体液的HCP&nbsp;预防性使用直接作用抗病毒药物｡发现HCV RNA&nbsp;阳性的患者或HCP时应及时治疗｡</p>, tagList=[TagDto(tagId=589, tagName=丙型肝炎)], categoryList=[CategoryDto(categoryId=35, categoryName=预防医学, tenant=100), CategoryDto(categoryId=75, categoryName=职业安全, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=589, guiderKeyword=丙型肝炎, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4140, appHits=58, showAppHits=0, pcHits=810, showPcHits=4082, likes=1, shares=8, comments=5, approvalStatus=1, publishedTime=Wed Nov 18 00:59:52 CST 2020, publishedTimeString=2020-07-24, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Wed Nov 18 00:58:08 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 11:10:48 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 CDC指南：卫生保健人员潜在暴露HCV的检测与临床管理.pdf)])
2020 CDC指南：卫生保健人员潜在暴露HCV的检测与临床管理.pdf
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=901669, encodeId=2c2190166919, content=这一点特别重要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201118/644810206ca744f48355b4fc9381cc58/9cfe32903b6a495d8bdfc124267ba3d3.jpg, createdBy=ef782028905, createdName=种鱼的猫猫, createdTime=Tue Nov 24 09:31:00 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900410, encodeId=eddd900410c3, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac555424952, createdName=ms8000001754662727, createdTime=Thu Nov 19 10:36:02 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900349, encodeId=1dd890034943, content=阅读谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Thu Nov 19 07:26:36 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900246, encodeId=7af990024612, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b4b4230603, createdName=13df4a40m17暂无昵称, createdTime=Wed Nov 18 17:43:49 CST 2020, time=2020-11-18, status=1, ipAttribution=)]
    2020-11-24 种鱼的猫猫

    这一点特别重要

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=901669, encodeId=2c2190166919, content=这一点特别重要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201118/644810206ca744f48355b4fc9381cc58/9cfe32903b6a495d8bdfc124267ba3d3.jpg, createdBy=ef782028905, createdName=种鱼的猫猫, createdTime=Tue Nov 24 09:31:00 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900410, encodeId=eddd900410c3, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac555424952, createdName=ms8000001754662727, createdTime=Thu Nov 19 10:36:02 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900349, encodeId=1dd890034943, content=阅读谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Thu Nov 19 07:26:36 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900246, encodeId=7af990024612, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b4b4230603, createdName=13df4a40m17暂无昵称, createdTime=Wed Nov 18 17:43:49 CST 2020, time=2020-11-18, status=1, ipAttribution=)]
    2020-11-19 ms8000001754662727

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=901669, encodeId=2c2190166919, content=这一点特别重要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201118/644810206ca744f48355b4fc9381cc58/9cfe32903b6a495d8bdfc124267ba3d3.jpg, createdBy=ef782028905, createdName=种鱼的猫猫, createdTime=Tue Nov 24 09:31:00 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900410, encodeId=eddd900410c3, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac555424952, createdName=ms8000001754662727, createdTime=Thu Nov 19 10:36:02 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900349, encodeId=1dd890034943, content=阅读谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Thu Nov 19 07:26:36 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900246, encodeId=7af990024612, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b4b4230603, createdName=13df4a40m17暂无昵称, createdTime=Wed Nov 18 17:43:49 CST 2020, time=2020-11-18, status=1, ipAttribution=)]
    2020-11-19 刘煜

    阅读谢谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=901669, encodeId=2c2190166919, content=这一点特别重要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201118/644810206ca744f48355b4fc9381cc58/9cfe32903b6a495d8bdfc124267ba3d3.jpg, createdBy=ef782028905, createdName=种鱼的猫猫, createdTime=Tue Nov 24 09:31:00 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900410, encodeId=eddd900410c3, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac555424952, createdName=ms8000001754662727, createdTime=Thu Nov 19 10:36:02 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900349, encodeId=1dd890034943, content=阅读谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Thu Nov 19 07:26:36 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900246, encodeId=7af990024612, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b4b4230603, createdName=13df4a40m17暂无昵称, createdTime=Wed Nov 18 17:43:49 CST 2020, time=2020-11-18, status=1, ipAttribution=)]
    2020-11-18 13df4a40m17暂无昵称

    学习了

    0

相关指南

2020 CDC建议：成人丙型肝炎的筛查

美国疾病控制与预防中心(CDC,Centers for Disease Control and Prevention) · 2020-04-10

2020 NASPGHAN意见书：丙型肝炎

北美小儿胃肠病、肝脏病和营养学会(NASPGHAN,North American society for pediatric gastroenterology,Hepatology,and nutrition) · 2020-08-20

2019 JSH指南：丙型肝炎病毒感染的管理

日本肝脏学会(JSH,The Japan Society of Hepatology) · 2020-04-28

丙型肝炎防治指南（2019年版）

中华医学会肝病学分会(Chinese Society of Hepatology, CMA) · 2019-12-20

慢性肾脏病的丙型肝炎病毒感染的预防，诊断，评估和治疗指南2019

肾脏病相关专家小组（统称） · 2019-09-27

慢性肾脏病合并丙型肝炎病毒感染诊断及治疗的专家共识

肾脏病相关专家小组（统称） · 2019-05-30

拓展阅读

2014 EASL 丙型肝炎诊疗推荐建议

欧洲肝脏研究学会(EASL,European Association for the Study of the Liver) · 2014-04-11

2014 英国指南共识：丙型肝炎的管理和直接抗病毒治疗

外国肝病科相关专家小组（统称） · 2014-04-22

2015 CASL共识指南：慢性丙型肝炎的管理（更新版）

加拿大肝病学会(CASL,Cannadian Association for the Study of the Liver) · 2015-01-13

丙型肝炎防治指南(2015更新版)

中华医学会肝病学分会(Chinese Society of Hepatology, CMA) · 2016-04-20

2016年APASL共识建议：丙型肝炎的治疗

亚太肝脏研究学会(APASL,Asian-Pacific Association for the Study of the Liver) · 2016-06-08

丙型肝炎直接抗病毒药物临床试验评价专家建议

中国肝病科相关专家小组（统称） · 2016-06-08